Michael H. Wilson

Array ( [id] => 655183 [patent_doc_number] => 07109299 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-19 [patent_title] => 'Peptides and compounds that bind to the IL-5 receptor' [patent_app_type] => utility [patent_app_number] => 10/168372 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 18803 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/109/07109299.pdf [firstpage_image] =>[orig_patent_app_number] => 10168372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534835 [patent_doc_number] => 06489290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-03 [patent_title] => 'Antiplatelet agent' [patent_app_type] => B2 [patent_app_number] => 09/381261 [patent_app_country] => US [patent_app_date] => 1999-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12595 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489290.pdf [firstpage_image] =>[orig_patent_app_number] => 09381261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342404 [patent_doc_number] => 06586402 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'LH-RH peptide analogues, their uses and pharmaceutical compositions containing them' [patent_app_type] => B1 [patent_app_number] => 09/450443 [patent_app_country] => US [patent_app_date] => 1999-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14346 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586402.pdf [firstpage_image] =>[orig_patent_app_number] => 09450443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446798 [patent_doc_number] => 06369030 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Inhibitors of histone acetyltransferases (HATs) and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/451034 [patent_app_country] => US [patent_app_date] => 1999-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 7787 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369030.pdf [firstpage_image] =>[orig_patent_app_number] => 09451034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521719 [patent_doc_number] => 06414123 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Method for purifying FSH' [patent_app_type] => B1 [patent_app_number] => 09/442132 [patent_app_country] => US [patent_app_date] => 1999-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11539 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/414/06414123.pdf [firstpage_image] =>[orig_patent_app_number] => 09442132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534842 [patent_doc_number] => 06489292 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Stable aqueous insulin preparations without phenol and cresol' [patent_app_type] => B1 [patent_app_number] => 09/441702 [patent_app_country] => US [patent_app_date] => 1999-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4076 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489292.pdf [firstpage_image] =>[orig_patent_app_number] => 09441702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467197 [patent_doc_number] => 06458760 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Method for treating tissue damaged from ischemia' [patent_app_type] => B1 [patent_app_number] => 09/439705 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11576 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458760.pdf [firstpage_image] =>[orig_patent_app_number] => 09439705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4087268 [patent_doc_number] => 06162904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Manufacturing method for intraveneously administrable immune globulin and resultant product' [patent_app_type] => 1 [patent_app_number] => 9/421405 [patent_app_country] => US [patent_app_date] => 1999-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7142 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162904.pdf [firstpage_image] =>[orig_patent_app_number] => 421405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470153 [patent_doc_number] => 06407068 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Method of treating humans with diseases characterized by high secretion of cytokines from macrophage cells' [patent_app_type] => B1 [patent_app_number] => 09/421162 [patent_app_country] => US [patent_app_date] => 1999-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6166 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407068.pdf [firstpage_image] =>[orig_patent_app_number] => 09421162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495403 [patent_doc_number] => 06403564 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection' [patent_app_type] => B1 [patent_app_number] => 09/417884 [patent_app_country] => US [patent_app_date] => 1999-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15213 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403564.pdf [firstpage_image] =>[orig_patent_app_number] => 09417884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861190 [patent_doc_number] => 20030092198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'SITE-SPECIFIC LABELING OF DISULFIDE-CONTAINING TARGETING VECTORS' [patent_app_type] => new [patent_app_number] => 09/417109 [patent_app_country] => US [patent_app_date] => 1999-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8579 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092198.pdf [firstpage_image] =>[orig_patent_app_number] => 09417109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1333465 [patent_doc_number] => 06596728 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives, process for their preparation, pharmaceuticals comprising these compounds and their use' [patent_app_type] => B1 [patent_app_number] => 09/410083 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10626 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 753 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596728.pdf [firstpage_image] =>[orig_patent_app_number] => 09410083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411504 [patent_doc_number] => 06300470 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Antibiotic cryptdin peptides and methods of their use' [patent_app_type] => 1 [patent_app_number] => 9/397386 [patent_app_country] => US [patent_app_date] => 1999-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 40 [patent_no_of_words] => 18389 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300470.pdf [firstpage_image] =>[orig_patent_app_number] => 397386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4087139 [patent_doc_number] => 06162895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Peracylated insulin compositions and process for making the same' [patent_app_type] => 1 [patent_app_number] => 9/392416 [patent_app_country] => US [patent_app_date] => 1999-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2070 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162895.pdf [firstpage_image] =>[orig_patent_app_number] => 392416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467206 [patent_doc_number] => 06458764 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'GRF analogs with increased biological potency' [patent_app_type] => B1 [patent_app_number] => 09/389486 [patent_app_country] => US [patent_app_date] => 1999-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14612 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458764.pdf [firstpage_image] =>[orig_patent_app_number] => 09389486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359274 [patent_doc_number] => 06191112 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Human therapeutic uses of BPI protein products' [patent_app_type] => 1 [patent_app_number] => 9/388758 [patent_app_country] => US [patent_app_date] => 1999-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12856 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/191/06191112.pdf [firstpage_image] =>[orig_patent_app_number] => 388758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7013964 [patent_doc_number] => 20010051146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-13 [patent_title] => 'AGENT FOR PREVENTING AND/OR TREATING MULTIPLE ORGAN FAILURE' [patent_app_type] => new [patent_app_number] => 09/180599 [patent_app_country] => US [patent_app_date] => 1999-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4432 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20010051146.pdf [firstpage_image] =>[orig_patent_app_number] => 09180599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1068898 [patent_doc_number] => 06844424 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-18 [patent_title] => 'Method for obtaining avian biological products' [patent_app_type] => utility [patent_app_number] => 09/763724 [patent_app_country] => US [patent_app_date] => 1999-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1301 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/844/06844424.pdf [firstpage_image] =>[orig_patent_app_number] => 09763724 [rel_patent_id] =>[rel_patent_doc_number] =>)